UCB reported EUR1.29B in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Alcon AG USD 297M 16M Mar/2026
Almirall EUR 71.55M 41.32M Jun/2026
Amarin USD -2.26M 564K Dec/2025
argenx SE USD 493M 99M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.75B 515M Jun/2026
Orion EUR 176.6M 61.8M Jun/2026
Recordati EUR 203.76M 27.35M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
UCB EUR 1.29B 571M Dec/2025
Unibail Rodamco EUR 844.1M 102.4M Dec/2025